Announced Thu, 23 Apr · 19:00 IST

Inventurus Knowledge Solutions Limited has informed the Exchange regarding a press release dated April 23, 2026, titled "Press Release IKS Health Announces Agreement to Acquire TruBridge to Strengthen Access to Rural and Community-Based Healthcare.".

Listed Co AcquisitionStrategic Transactions View source PDF

IKS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+4.7%1-day move
₹1435.40
prior close
₹1476.90
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.0+5.3+5.2+3.2+4.7+6.2+8.8+15.0+16.9+16.2+11.0+14.9+19.8+23.0
Up moveDown movePending
AI summary

IKS Health, the listed parent company of Inventurus Knowledge Solutions Limited (NSE: IKS, BSE: 544309), has entered into a definitive agreement to acquire TruBridge, Inc. (NASDAQ: TBRG), a U.S.-based healthcare technology provider serving rural and community hospitals. TruBridge shareholders will receive $26.25 per share in cash, representing an all-cash acquisition deal. The transaction has been approved by boards of all three companies and is expected to close in Q3 2026, subject to shareholder approvals and regulatory clearances including HSR review. IKS will fund the acquisition primarily through new debt financing arranged by Citibank, JPMorganChase, and Deutsche Bank. TruBridge's largest shareholders (representing ~27% of shares) have already committed to vote in favor. Post-acquisition, the combined entity will serve over 2,000 healthcare organizations and 150,000+ clinicians.

Likely market impact

This acquisition expands IKS Health's presence in the rural healthcare segment and creates a larger global healthcare technology platform. The debt-funded deal may have near-term financial implications but strengthens IKS's market position in the U.S. healthcare IT space.